Recently, it was shown that cyclin-dependent kinase 5 (CDK5)-mediated phosphorylation of PPARγ may be involved in the pathogenesis of insulin resistance and glucose-lowering effects, which provides a new angle to understand the mechanisms of PPARγ activation27. This evidence concerns the gene PPARG and Insulin resistance.